Epidemiology of drug-resistant malaria.

[1]  J. E. Hyde,et al.  Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? , 2001, Trends in parasitology.

[2]  C. Wongsrichanalai,et al.  In vitro susceptibility of Plasmodium falciparum isolates from Myanmar to antimalarial drugs. , 2001, The American journal of tropical medicine and hygiene.

[3]  P. Winstanley,et al.  Modern chemotherapeutic options for malaria. , 2001, The Lancet. Infectious diseases.

[4]  E. Nduati,et al.  Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania , 2001, The Lancet.

[5]  J. Kublin,et al.  Plasmodium falciparum crossresistance between trimethoprim and pyrimethamine , 2001, The Lancet.

[6]  T. Wellems,et al.  Chloroquine-resistant malaria. , 2001, The Journal of infectious diseases.

[7]  L. H. da Silva,et al.  Analysis of the PfCRT K76T mutation in Plasmodium falciparum isolates from the Amazon region of Brazil. , 2001, The Journal of infectious diseases.

[8]  P. Ringwald,et al.  Analysis of the key pfcrt point mutation and in vitro and in vivo response to chloroquine in Yaoundé, Cameroon. , 2001, The Journal of infectious diseases.

[9]  P. Nasveld,et al.  Sequence polymorphisms in pfcrt are strongly associated with chloroquine resistance in Plasmodium falciparum. , 2001, The Journal of infectious diseases.

[10]  H. Babiker,et al.  High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance Gene pfmdr1. , 2001, The Journal of infectious diseases.

[11]  Ashutosh Kumar Singh,et al.  Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda. , 2001, The Journal of infectious diseases.

[12]  M. Dgedge,et al.  Prevalence of the K76T mutation in the putative Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene and its relation to chloroquine resistance in Mozambique. , 2001, The Journal of infectious diseases.

[13]  J. Le bras,et al.  Analysis of pfcrt point mutations and chloroquine susceptibility in isolates of Plasmodium falciparum. , 2001, Molecular and biochemical parasitology.

[14]  T. Jelínek,et al.  Patterns of Plasmodium falciparum Drug Resistance in Nonimmune Travellers to Africa , 2001, European Journal of Clinical Microbiology and Infectious Diseases.

[15]  F. Ntoumi,et al.  Molecular analysis of DHFR and DHPS genes in P. falciparum clinical isolates from the Haut--Ogooué region in Gabon. , 2001, Acta tropica.

[16]  K. Kain,et al.  Plasmodium falciparum malaria in Laos: chloroquine treatment outcome and predictive value of molecular markers. , 2001, The Journal of infectious diseases.

[17]  C. Wongsrichanalai,et al.  Drug resistant malaria on the Thai-Myanmar and Thai-Cambodian borders. , 2001, The Southeast Asian journal of tropical medicine and public health.

[18]  I. Adagu,et al.  Plasmodium falciparum: linkage disequilibrium between loci in chromosomes 7 and 5 and chloroquine selective pressure in Northern Nigeria , 2001, Parasitology.

[19]  X. Su,et al.  A molecular marker for chloroquine-resistant falciparum malaria. , 2001, The New England journal of medicine.

[20]  A. Cowman,et al.  Mutations in the pfmdr1, dhfr and dhps genes of Plasmodium falciparum are associated with in-vivo drug resistance in West Papua, Indonesia. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[21]  S. Meshnick,et al.  The History of Antimalarial Drugs , 2001 .

[22]  J. Breman,et al.  The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. , 2001, The American journal of tropical medicine and hygiene.

[23]  J. Trape.  The public health impact of chloroquine resistance in Africa. , 2001, The American journal of tropical medicine and hygiene.

[24]  D. Wirth,et al.  Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase of isolates from the Amazon region of Brazil. , 2000, Memorias do Instituto Oswaldo Cruz.

[25]  T. Werf,et al.  Chloroquine‐ and sulfadoxine‐pyrimethamine‐resistant falciparum malaria in vivo– a pilot study in rural Zambia , 2000, Tropical medicine & international health : TM & IH.

[26]  J. Wootton,et al.  Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. , 2000, Molecular cell.

[27]  P. Ringwald,et al.  Chimiorésistance de P. falciparum en milieu urbain à Yaoundé, Cameroun. Part 1: S urveillance in vitro et in vivo de la résistance de Plasmodium falciparumà la chloroquine entre 1994 et 1999 à Yaoundé, Cameroun , 2000 .

[28]  U. d’Alessandro,et al.  Modelling a predictable disaster: the rise and spread of drug-resistantmalaria. , 2000, Parasitology today.

[29]  Q. Cheng,et al.  Mutations in Plasmodium falciparumCytochrome b That Are Associated with Atovaquone Resistance Are Located at a Putative Drug-Binding Site , 2000, Antimicrobial Agents and Chemotherapy.

[30]  Richard N. Price,et al.  Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study , 2000, The Lancet.

[31]  C. Wongsrichanalai,et al.  Antimalarial drug combination policy: a caveat , 2000, The Lancet.

[32]  M. Duraisingh,et al.  The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. , 2000, Molecular and biochemical parasitology.

[33]  A. Nzila,et al.  Towards an Understanding of the Mechanism of Pyrimethamine-Sulfadoxine Resistance in Plasmodium falciparum: Genotyping of Dihydrofolate Reductase and Dihydropteroate Synthase of Kenyan Parasites , 2000, Antimicrobial Agents and Chemotherapy.

[34]  N. Élissa,et al.  Sulfadoxine-pyrimethamine for the treatment of Plasmodium falciparum malaria in Gabonese children. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[35]  I. Adagu,et al.  Correlation of in vivo‐resistance to chloroquine and allelic polymorphisms in Plasmodium falciparum isolates from Uganda , 2000, Tropical medicine & international health : TM & IH.

[36]  A. Nzila,et al.  The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi, Kenya. , 2000, The American journal of tropical medicine and hygiene.

[37]  K. Kirk,et al.  Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum , 2000, Nature.

[38]  S. Meshnick,et al.  Mechanisms of Artemisinin Resistance in the Rodent Malaria Pathogen Plasmodium yoelii , 2000, Antimicrobial Agents and Chemotherapy.

[39]  P. Bloland,et al.  Combination therapy for malaria in Africa: hype or hope? , 2000, Bulletin of the World Health Organization.

[40]  S. Krishna,et al.  The pfmdr1 Gene Is Associated with a Multidrug-Resistant Phenotype in Plasmodium falciparumfrom the Western Border of Thailand , 1999, Antimicrobial Agents and Chemotherapy.

[41]  A. Cowman,et al.  Analysis of mefloquine resistance and amplification of pfmdr1 in multidrug-resistant Plasmodium falciparum isolates from Thailand. , 1999, The American journal of tropical medicine and hygiene.

[42]  C. Plowe,et al.  Point mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum isolates from Venezuela. , 1999, The American journal of tropical medicine and hygiene.

[43]  C. Masimirembwa,et al.  Molecular epidemiology of Plasmodium falciparum antifolate resistance in Vietnam: genotyping for resistance variants of dihydropteroate synthase and dihydrofolate reductase. , 1999, International journal of antimicrobial agents.

[44]  N. White,et al.  Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria. , 1999, The American journal of tropical medicine and hygiene.

[45]  K. Floyd,et al.  Transmission control and drug resistance in malaria: a crucial interaction. , 1999, Parasitology Today.

[46]  N. White,et al.  Antimalarial drug resistance and combination chemotherapy. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[47]  R. Witzig,et al.  Malaria reemergence in the Peruvian Amazon region. , 1999, Emerging infectious diseases.

[48]  W. Wernsdorfer,et al.  Follow-up of the susceptibility of Plasmodium falciparum to antimalarials in Gabon. , 1998, The American journal of tropical medicine and hygiene.

[49]  D. Wirth,et al.  Characterization of Plasmodium falciparum isolated from the Amazon region of Brazil: evidence for quinine resistance. , 1998, The American journal of tropical medicine and hygiene.

[50]  K. Marsh,et al.  Quinine sensitivity of isolates of Plasmodium falciparum from the coast of Kenya. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[51]  I. Adagu,et al.  Pfmdr1Asn1042AspandAsp1246TyrPolymorphisms, Thought to Be Associated with Chloroquine Resistance, Are Present in Chloroquine-Resistant and -Sensitive Brazilian Field Isolates ofPlasmodium falciparum , 1998 .

[52]  O. Doumbo,et al.  Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. , 1997, The Journal of infectious diseases.

[53]  C. Drakeley,et al.  Polymorphism of the Pfmdr1 gene and chloroquine resistance in Plasmodium falciparum in The Gambia. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[54]  M. Alin.  In vitro susceptibility of Tanzanian wild isolates of Plasmodium falciparum to artemisinin, chloroquine, sulfadoxine/pyrimethamine and mefloquine , 1997, Parasitology.

[55]  W. Wernsdorfer,et al.  High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[56]  H. Webster,et al.  Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. , 1996, The American journal of tropical medicine and hygiene.

[57]  J. Alvar,et al.  In vitro susceptibility of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine, and sulfadoxine/pyrimethamine in Equatorial Guinea. , 1995, The American journal of tropical medicine and hygiene.

[58]  C. Wilson,et al.  Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from subsaharan Africa. , 1995, Molecular and biochemical parasitology.

[59]  C. Canfield,et al.  Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro. , 1995, Experimental parasitology.

[60]  W. Wernsdorfer,et al.  Plasmodium falciparum: susceptibility in vitro and in vivo to chloroquine and sulfadoxine-pyrimethamine in Ghanaian schoolchildren. , 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[61]  G. Shanks.  1993 Sir Henry Wellcome Medal and Prize recipient. The rise and fall of mefloquine as an antimalarial drug in South East Asia. , 1994, Military medicine.

[62]  W. Wernsdorfer.  Epidemiology of drug resistance in malaria. , 1994, Acta tropica.

[63]  C. Wilson,et al.  Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. , 1993, Molecular and biochemical parasitology.

[64]  R. Moyou,et al.  Mefloquine resistant malaria in Cameroon and correlation with resistance to quinine. , 1992, Memorias do Instituto Oswaldo Cruz.

[65]  T. Wellems,et al.  Genetic mapping of the chloroquine-resistance locus on Plasmodium falciparum chromosome 7. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[66]  W. Wernsdorfer,et al.  The dynamics of drug resistance in Plasmodium falciparum. , 1991, Pharmacology & therapeutics.

[67]  P. Phillips-Howard,et al.  The epidemiology of drug-resistant malaria. , 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[68]  W. Wernsdorfer,et al.  Serial studies on the evolution of chloroquine resistance in an area of East Africa receiving intermittent malaria chemosuppression. , 1985, Bulletin of the World Health Organization.

[69]  E. Hurwitz,et al.  RESISTANCE OF PLASMODIUM FALCIPARUM MALARIA TO SULFADOXINE-PYRIMETHAMINE ('FANSIDAR') IN A REFUGEE CAMP IN THAILAND , 1981, The Lancet.

[70]  W. Peters,et al.  Chemotherapy and drug resistance in malaria. , 1970 .

[71]  Peter B. Bloland,et al.  Drug resistance in malaria. , 1990, Recenti progressi in medicina.